BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34943021)

  • 1. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity.
    Ramkumar V; Mukherjea D; Dhukhwa A; Rybak LP
    Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Receptor Potential Channels and Auditory Functions.
    Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
    Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.
    Sheth S; Mukherjea D; Rybak LP; Ramkumar V
    Front Cell Neurosci; 2017; 11():338. PubMed ID: 29163050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
    Tan WJT; Vlajkovic SM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local Drug Delivery for Prevention of Hearing Loss.
    Rybak LP; Dhukhwa A; Mukherjea D; Ramkumar V
    Front Cell Neurosci; 2019; 13():300. PubMed ID: 31338024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
    Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
    Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sound preconditioning therapy inhibits ototoxic hearing loss in mice.
    Roy S; Ryals MM; Van den Bruele AB; Fitzgerald TS; Cunningham LL
    J Clin Invest; 2013 Nov; 123(11):4945-9. PubMed ID: 24216513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
    J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin Protects Against Cisplatin Ototoxicity by Changing the STAT3/STAT1 Ratio and Activating Cannabinoid (CB2) Receptors in the Cochlea.
    Bhatta P; Dhukhwa A; Sheehan K; Al Aameri RFH; Borse V; Ghosh S; Sheth S; Mamillapalli C; Rybak L; Ramkumar V; Mukherjea D
    Sci Rep; 2019 Mar; 9(1):4131. PubMed ID: 30858408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
    Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
    Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Strategies to Combat Cisplatin-Induced Ototoxicity.
    Yu D; Gu J; Chen Y; Kang W; Wang X; Wu H
    Front Pharmacol; 2020; 11():999. PubMed ID: 32719605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention.
    Rybak LP; Mukherjea D; Ramkumar V
    Semin Hear; 2019 May; 40(2):197-204. PubMed ID: 31036996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss.
    Tan WJT; Song L
    Hear Res; 2023 Jul; 434():108783. PubMed ID: 37167889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity.
    Jamesdaniel S; Rathinam R; Neumann WL
    Redox Biol; 2016 Dec; 10():257-265. PubMed ID: 27821327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulating the blood labyrinth barrier with mannitol to prevent cisplatin-induced hearing loss.
    Noman A; Mukherjee S; Le TN
    Hear Res; 2022 Dec; 426():108646. PubMed ID: 36403317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of adenosine receptors in the cochlea by cisplatin.
    Ford MS; Nie Z; Whitworth C; Rybak LP; Ramkumar V
    Hear Res; 1997 Sep; 111(1-2):143-52. PubMed ID: 9307320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin protects against cisplatin-induced hearing loss in mice.
    Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
    Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity.
    Chen Y; Bielefeld EC; Mellott JG; Wang W; Mafi AM; Yamoah EN; Bao J
    J Assoc Res Otolaryngol; 2021 Apr; 22(2):107-126. PubMed ID: 33415542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CORM‑2 reduces cisplatin accumulation in the mouse inner ear and protects against cisplatin-induced ototoxicity.
    Lyu AR; Jeong Kim S; Jung Park M; Park YH
    J Adv Res; 2023 Nov; ():. PubMed ID: 38030129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.